cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination
Oasis Launches Hemp-Derived Mixer
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products
cbdMD Appoints Wade Brown Chief Marketing Officer
Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results
cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript
Full Transcript: cbdMD Q2 2026 Earnings Call
cbdMD Q2 EPS $(0.08) Misses $(0.05) Estimate, Sales $5.640M Beat $5.292M Estimate
cbdMD, Inc. Q3 2026 Earnings Call Summary
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results
cbdMD Shareholders Approve Potential Reverse Stock Split Of Up To 1-for-10
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
cbdMD Introduces Clinical Healthcare Channel
cbdMD, Inc. Q1 2026 Earnings Call Summary
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ...
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.